MindWalk Holdings strengthens Boston development leadership
The company said its pipeline is advancing toward preclinical efficacy studies.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The company said its pipeline is advancing toward preclinical efficacy studies.
For best results when printing this announcement, please click on link below: MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies Senior appointments from Pfizer, Novartis, Arbor Biotechnologies, and Orum Therapeutics bring preclinical develop